Breaking News
It Begins: Mamdani Plans First NYC Property Tax Hike In Decades To Plug $5 Billion Hole
SpaceX Enters Secretive Pentagon Contest To Build Voice-Controlled Drone Swarm Tech: Report
When Both Sides Go Quiet
Bayer Soars After $10.5 Billion Settlement On Current And Future Roundup Cancer Lawsuits
Top Tech News
New Spray-on Powder Instantly Seals Life-Threatening Wounds in Battle or During Disasters
AI-enhanced stethoscope excels at listening to our hearts
Flame-treated sunscreen keeps the zinc but cuts the smeary white look
Display hub adds three more screens powered through single USB port
We Finally Know How Fast The Tesla Semi Will Charge: Very, Very Fast
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Epidemiologist Nicolas Hulscher on Brannon Howse Live
Yesterday, I joined Brannon Howse Live to share some long-overdue good news. We discussed emerging breakthroughs in cancer research, the extraordinary promise of natural compounds like dandelion root and high-dose vitamin C, and a major development in the mRNA arena:
Dandelion Root Extract: A Common Weed With Anti-Cancer Power
·
Dec 9
A remarkable peer-reviewed study found that aqueous dandelion root extract kills 95% of cancer cells in vitro and reduces human colon tumor growth by over 90% in mice — with zero toxicity.
Tumors in untreated mice grew aggressively.
Tumors in the treated group barely grew at all.
Human trials were planned but mysteriously never funded — likely because a common backyard plant is not profitable for the chemo-industrial complex.
This study fits into a larger body of over 1,100 peer-reviewed papers showing anti-cancer effects from natural, non-toxic compounds — an entire therapeutic frontier long ignored because it threatens the economics of conventional oncology.